Profile for Brazil Patent: 112014030282
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Brazil Patent: 112014030282
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,403,170 | Jun 5, 2033 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| 11,139,056 | Jun 5, 2033 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| 9,633,575 | Jun 25, 2033 | Nalpropion | CONTRAVE | bupropion hydrochloride; naltrexone hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
